HAP’s Opioid Learning Action Network Frequently Asked Questions (FAQs)
What is the HAP Opioid Learning Action Network and why did HAP create it?
The HAP Opioid Learning Action Network (LAN) is a two-year learning collaborative designed to increase the number of patients entering evidence-based treatment for opioid use disorders (OUD) and to prevent overdose deaths. By working together hospitals can demonstrate their ability to adopt evidence-based best practices to address the opioid problem without the need for legislation or regulation, which may result in unintended consequences or become quickly out-of-date.
How will our hospital, patients, and communities benefit if we join?
- Get more people into treatment and prevent overdose deaths
- Improve patients’ experience and outcomes
- Reduce learning and implementation costs by using the LAN’s free, shared resources
- Gain efficiencies in understanding and deploying available regional resources
- Help your hospital get its share of OUD-related Department of Health quality incentives
- Provide continuing education credits for physicians, nurses, and social workers
Are there special requirements to join?
The key requirement is a commitment to help patients dealing with OUD. All licensed and regulated hospitals and health systems in Pennsylvania may participate.
What kind of commitment do we have to make in time, money, and resources?
- There is no financial obligation
- Attend the annual program during 2019 and 2020, participate in periodic regional events and educational programs
- Measure and track performance in key process areas and share successful efforts through HAP’s data portal and collaborative website
How can I access additional information about the HAP Opioid LAN before the official launch during August?
General information and updates will be available on the HAP Opioid LAN page at the HAP website. The LAN team also will provide periodic email updates to participants. Following the launch during August, the collaborative portal will serve as the main online resource.
I have been involved in other HAP opioid-related work. Does my hospital still have to sign-up for the LAN?
Yes, a hospital/health system executive must sign the commitment letter. No matter where you are in your work to address the opioid crisis, HAP’s Opioid LAN collaborative will accelerate your progress to improve outcomes.
Is the LAN limited to hospital or health system designees or may we include community stakeholders or other partners?
While initially focused on hospitals, as the LAN initiative evolves there likely will be opportunities to engage your community partners.
What is the deadline to sign up for the HAP Opioid LAN?
The deadline to sign up is July 15, 2019.
Who are you expecting to represent organizations within the LAN, an administrator, physician, both?
We are requesting that your Executive Sponsor (CEO, COO, CMO, CNO) complete the initial commitment form and designate one key contact for ongoing communication. The key contact could be either a physician, staff person, or an administrator; whoever is anchoring your overdose response approach within your organization. We contemplate that organizations will join as an entire health system or as individual hospitals––either option is acceptable.
There will be an opportunity to identify additional participants in your enrollment survey.
How often would you expect the LAN to meet, and will phone participation be adequate for the most part or will live participation be expected for the most part?
We will host two in-person meetings (one per year with the first one scheduled for August 20, 2019) and regional meetings as necessary to support the work and facilitate information-sharing. Similar to our Hospital Improvement Innovation Network effort, we will make the bulk of our content available via webinars, office hours, virtual small group discussions, and other distance learning opportunities.
For more information: Contact Jennifer Jordan, HAP’s vice president, regulatory advocacy, about program goals, requirements, and organization.
Topics: Substance Use Disorder
Revision Date: 6/1/2019
Return to Previous Page